Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$2.27B
-4.4% from 2023
Prescriptions
146K
$15,477.88 per claim
Patients
15K
8,828 prescribers
Total spending, 2024
$2.27B
$147,628.95 per patient
Medicare prescription drug plans paid $2.27B for Imbruvica in 2024, for 146,351 prescriptions and refills to 15,343 patients (down 4.4% from 2023). The average cost per claim was $15,477.88.
California had the highest Medicare cost for Imbruvica in 2024: $205.8M for 13,081 claims, followed by New York ($181.0M).
Josie Montegaard, nurse practitioner in Boston, MA, had the highest Medicare cost for Imbruvica in 2024: 231 claims costing $3.6M.
Imbruvica is made by AbbVie Inc. (ABBV), listed in the Medicare spending data as Pharmacyclics,.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Josie Montegaard Boston, MA | Nurse Practitioner | 231 | 25 | $3.6M |
| Sami N Malek Ann Arbor, MI | Hematology | 163 | 18 | $2.8M |
| Erin M Pettijohn |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 10,064 | 195,587 | 22,193 | $2.85B |
| 2023 | 9,115 | 151,924 | 17,085 | $2.37B |
| 2024 | 8,828 | 146,351 | 15,343 | $2.27B |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 183 |
| 18 |
| $2.8M |
| Michael P Carroll Sacramento, CA | Hematology-Oncology | 160 | 17 | $2.7M |
| Samer E Bibawi Richardson, TX | Hematology-Oncology | 147 | 15 | $2.5M |
| Thomas J Kipps La Jolla, CA | Hematology-Oncology | 156 | 16 | $2.5M |
| Rajeev Kulkarni Troy, OH | Hematology-Oncology | 154 | 15 | $2.4M |
| Jeffrey H Margolis Madison Heights, MI | Hematology-Oncology | 144 | 13 | $2.3M |
| Catherine A Flynn Boston, MA | Nurse Practitioner | 153 | 22 | $2.3M |
| Eric D Batts Holland, MI | Hematology-Oncology | 161 | 14 | $2.3M |
| Jose M Tongol Albany, GA | Hematology-Oncology | 139 | 14 | $2.3M |
| Antoine E Chahine Canfield, OH | Medical Oncology | 140 | 12 | $2.2M |
| Michael Y Choi San Diego, CA | Hematology-Oncology | 147 | 16 | $2.2M |
| Sanjaykumar J Hapani Edmond, OK | Medical Oncology | 139 | 16 | $2.2M |
| Tania Orzol Rochester, NY | Nurse Practitioner | 119 | 19 | $2.2M |
| Nicholas O Iannotti Port St Lucie, FL | Hematology-Oncology | 140 | 14 | $2.1M |
| Matthew E Adess Highland Park, IL | Medical Oncology | 135 | 13 | $2.1M |
| Mark E Dailey Hartford, CT | Medical Oncology | 111 | Under 11 | $2.1M |
| James L Rubenstein San Francisco, CA | Medical Oncology | 79 | 11 | $2.1M |
| Mohammad I Khan Louisville, KY | Hematology-Oncology | 127 | 11 | $2.0M |
| Pamela R Sinclair Rock Hill, SC | Medical Oncology | 123 | 11 | $2.0M |
| Joseph D Te St George, UT | Hematology-Oncology | 123 | 11 | $2.0M |
| Robert M Zielinski Williamsville, NY | Hematology | 124 | 13 | $1.9M |
| Hassan I Tahsildar Green Bay, WI | Medical Oncology | 119 | 13 | $1.9M |
| Jorge Castillo Boston, MA | Hematology-Oncology | 134 | 23 | $1.9M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Pharmacyclics, ABBV | 146,416 | $2.27B |